期刊文献+

Histopathological evaluation of recurrent hepatitis C after liver transplantation:A review 被引量:1

Histopathological evaluation of recurrent hepatitis C after liver transplantation:A review
下载PDF
导出
摘要 Although the morphological features of hepatitis C virus(HCV)recurrence after orthotopic liver transplantation(OLT)have been well established in the last decades,the differential diagnosis still represents a challenge for the pathologist,especially early recurrent hepatitis C vs mild acute cellular rejection.The present review focuses on the role of the pathologist and the pathology laboratory in the management of recipients with recurrent hepatitis C,the usefulness of early and late post-OLT liver biopsies,and the potential role of ancillary techniques(immunohistochemistry and reverse transcription-polymerase chain reaction,RT-PCR).The English literature on the topic is reviewed,focusing on the histopathology,the immunohistochemistry and the use of RT-PCR on HCV-positive post-OLT biopsies.The different histopathological illustrations of early and chronic recurrent hepatitis C are presented,with special focus on the main differential diagnoses and those features with prognostic relevance(cholestasis above all).The usefulness of ancillary techniques are discussed,especially HCV RNA quantitation by RT-PCR.Finally,the usefulness of long-term protocol biopsies is addressed:their usefulness for the study of allograft disease progression is clear,but their meaning in the long term is still debated.The significance of plasma cell infiltrate in HCV-positive allografts,the prognostic weight of graft steatosis,and the impact of donor age in recurrent hepatitis C also represent additional open issues. Although the morphological features of hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) have been well established in the last decades, the differential diagnosis still represents a challenge for the pathologist, especially early recurrent hepatitis C vs mild acute cellular rejection. The present review focuses on the role of the pathologist and the pathology laboratory in the management of recipients with recurrent hepatitis C, the usefulness of early and late post-OLT liver biopsies, and the potential role of ancillary techniques (immunohistochemistry and reverse transcription-polymerase chain reaction, RT-PCR). The English literature on the topic is reviewed, focusing on the histopathology, the immunohistochemistry and the use of RT-PCR on HCV-positive post-OLT biopsies. The different histopathological illustrations of early and chronic recurrent hepatitis C are presented, with special focus on the main differential diagnoses and those features with prognostic relevance (cholestasis above all). The usefulness of ancillary techniques are discussed, especially HCV RNA quantitation by RT-PCR. Finally, the usefulness of long-term protocol biopsies is addressed: their usefulness for the study of allograft disease progression is clear, but their meaning in the long term is still debated. The significance of plasma cell infiltrate in HCV-positive allografts, the prognostic weight of graft steatosis, and the impact of donor age in recurrent hepatitis C also represent additional open issues.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第11期2810-2824,共15页 世界胃肠病学杂志(英文版)
  • 相关文献

参考文献12

  • 1Eu Jin Lim,Ruth Chin,Peter W Angus,Joseph Torresi.Enhanced apoptosis in post-liver transplant hepatitis C:Effects of virus and immunosuppressants[J].World Journal of Gastroenterology,2012,18(18):2172-2179. 被引量:1
  • 2Pierluigi Toniutto,Carlo Fabris,Claudio Avellini,Rosalba Minisini,Davide Bitetto,Elisabetta Rossi,Carlo Smirne,Mario Pirisi.Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation[J].World Journal of Gastroenterology,2005,11(38):5944-5950. 被引量:1
  • 3Francesco Vasuri,Maria Cristina Morelli,Elisa Gruppioni,Michelangelo Fiorentino,Giorgio Ercolani,Matteo Cescon,Antonio Daniele Pinna,Walter Franco Grigioni,Antonia D’Errico-Grigioni.The meaning of tissue and serum HCV RNA quantitation in hepatitis C recurrence after liver transplantation: A retrospective study[J].Digestive and Liver Disease.2013(6)
  • 4Roger K. Moreira,Marcela Salomao,Elizabeth C. Verna,Robert S. Brown,Jay H. Lefkowitch.The Hepatitis Aggressiveness Score (HAS): A Novel Classification System for Post–Liver Transplantation Recurrent Hepatitis C[J].The American Journal of Surgical Pathology.2013(1)
  • 5Giacomo Germani,Emmanuel Tsochatzis,Vasilios Papastergiou,Andrew K Burroughs.HCV in liver transplantation[J].Seminars in Immunopathology.2013(1)
  • 6Sameh A. Fayek.The value of C4d deposit in post liver transplant liver biopsies[J].Transplant Immunology.2012(4)
  • 7Tomokazu Kawaoka,Shoichi Takahashi,Shintaro Takaki,Akira Hiramatsu,Koji Waki,Nobuhiko Hiraga,Daiki Miki,Masataka Tsuge,Michio Imamura,Yoshiiku Kawakami,Hiroshi Aikata,Hidenori Ochi,Takashi Onoe,Hirotaka Tashiro,Hideki Ohdan,Kazuaki Chayama.Interleukin‐28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation[J].Journal of Gastroenterology and Hepatology.2012(9)
  • 8Norah Terrault.Liver transplantation in the setting of chronic HCV[J].Best Practice & Research Clinical Gastroenterology.2012(4)
  • 9Vincenza Calvaruso,Amar Paul Dhillon,Emanuel Tsochatzis,Pinelopi Manousou,Federica Grillo,Giacomo Germani,David Patch,James O’Beirne,Andrew Kenneth Burroughs.Liver collagen proportionate area predicts decompensation in patients with recurrent hepatitis C virus cirrhosis after liver transplantation[J].Journal of Gastroenterology and Hepatology.2012(7)
  • 10Josh Levitsky,Maria Isabel Fiel,John P. Norvell,Edward Wang,Kymberly D. Watt,Michael P. Curry,Sumeet Tewani,Timothy M. McCashland,Maarouf A. Hoteit,Abraham Shaked,Samuel Saab,Amanda C. Chi,Amy Tien,Thomas D. Schiano.Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon[J].Gastroenterology.2012(5)

二级参考文献44

  • 1Xiu-Li Zhang Qi-Zhen Quan Zi-Qin Sun Yao-Jun Wang Xue-Liang Jiang Dong-Wang Wen-Bo Li Department of Gastroenterology,General Hospital of Jinan Military Command,Jinan 250031,Shandong Province,China.Protective effects of cyclosporine A on T-cell dependent ConA-induced liver injury in Kunming mice[J].World Journal of Gastroenterology,2001,7(4):569-571. 被引量:14
  • 2Robert Flisiak,Jerzy Jaroszewicz,Tadeusz W Lapiski,Iwona Flisiak,Danuta Prokopowiczi.Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-β1,metalloproteinase-1,and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C[J].World Journal of Gastroenterology,2005,11(43):6833-6838. 被引量:7
  • 3[1]McCaughan GW,Zekry A.Pathogenesis of hepatitis C virus recurrence in the liver allograft.Liver Transpl 2002;8:S7-13
  • 4[2]Berenguer M.Natural history of recurrent hepatitis C.Liver Transpl 2002;8:S14-18
  • 5[3]Mazuelos F,Abril J,Zaragoza C,Rubio E,Moreno JM,Turrion VS,Cuervas-Mons V.Cardiovascular morbidity and obesity in adult liver transplant recipients.Transplant Proc 2003;35:1909-1910
  • 6[4]Nair S,Verma S,Thuluvath PJ.Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States.Hepatology 2002;35:105-109
  • 7[5]Hourigan LF,Macdonald GA,Purdie D,Whitehall VH,Shorthouse C,Clouston A,Powell EE.Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.Hepatology 1999;29:1215-1219
  • 8[6]Adinolfi LE,Gambardella M,Andreana A,Tripodi MF,Utili R,Ruggiero G.Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.Hepatology 2001;33:1358-1364
  • 9[7]Monto A,Alonzo J,Watson JJ,Grunfeld C,Wright TL.Steatosis in chronic hepatitis C:relative contributions of obesity,diabetes mellitus,and alcohol.Hepatology 2002;36:729-736
  • 10[8]Ortiz V,Berenguer M,Rayon JM,Carrasco D,Berenguer J.Contribution of obesity to hepatitis C-related fibrosis progression.Am J Gastroenterol 2002;97:2408-2414

共引文献7

同被引文献83

  • 1Eric R Kallwitz.Recurrent hepatitis C virus after transplant and the importance of plasma cells on biopsy[J].World Journal of Gastroenterology,2013,19(2):158-160. 被引量:3
  • 2Josh Levitsky,Maria Isabel Fiel,John P. Norvell,Edward Wang,Kymberly D. Watt,Michael P. Curry,Sumeet Tewani,Timothy M. McCashland,Maarouf A. Hoteit,Abraham Shaked,Samuel Saab,Amanda C. Chi,Amy Tien,Thomas D. Schiano.Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon[J].Gastroenterology.2012(5)
  • 3Stefan G. Hübscher.What is the long-term outcome of the liver allograft?[J].Journal of Hepatology.2011(3)
  • 4Toru Ikegami,Tomoharu Yoshizumi,Ken Shirabe,Yoshihiko Maehara.Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation[J]. Journal of Hepatology . 2013
  • 5M. Castillo‐Rama,M. Sebagh,E. Sasatomi,P. Randhawa,K. Isse,A. D. Salgarkar,K. Ruppert,A. Humar,A. J. Demetris.“Plasma Cell Hepatitis” in Liver Allografts: Identification and Characterization of an IgG4‐Rich Cohort[J]. American Journal of Transplantation . 2013 (11)
  • 6Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group(J)Journal of Hepatology . 2004 (4)
  • 7Michael P. Manns,Albert J. Czaja,James D. Gorham,Edward L. Krawitt,Giorgina Mieli‐Vergani,Diego Vergani,John M. Vierling.??Diagnosis and management of autoimmune hepatitis(J)Hepatology . 2010 (6)
  • 8Maria Guido,Patrizia Burra.??De Novo Autoimmune Hepatitis after Liver Transplantation(J)Semin Liver Dis . 2011 (01)
  • 9X.-y. Zhao,M.I.A. Rakhda,T.-I. Wang,J.-d. Jia.??Immunoglobulin G4-Associated De Novo Autoimmune Hepatitis After Liver Transplantation for Chronic Hepatitis B- and C-Related Cirrhosis and Hepatocellular Carcinoma: A Case Report With Literature Review(J)Transplantation Proceedings . 2013 (2)
  • 10Marco Carbone,James M. Neuberger.??Autoimmune liver disease, autoimmunity and liver transplantation(J)Journal of Hepatology . 2014 (1)

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部